603351 威尔药业
交易中 06-03 13:25:44
资讯
新帖
简况
股市必读：威尔药业（603351）6月1日董秘有最新回复
证券之星 · 06-02 02:54
股市必读：威尔药业（603351）6月1日董秘有最新回复
每周股票复盘：威尔药业（603351）每股派现0.60元（含税）
证券之星 · 05-31
每周股票复盘：威尔药业（603351）每股派现0.60元（含税）
威尔药业（603351）披露2025年年度权益分派实施公告，5月28日股价上涨1.13%
证券之星 · 05-28
威尔药业（603351）披露2025年年度权益分派实施公告，5月28日股价上涨1.13%
每周股票复盘：威尔药业（603351）董事长及高管团队完成换届选举
证券之星 · 05-24
每周股票复盘：威尔药业（603351）董事长及高管团队完成换届选举
威尔药业（603351）披露2025年年度股东会决议公告，5月20日股价下跌0.59%
证券之星 · 05-20
威尔药业（603351）披露2025年年度股东会决议公告，5月20日股价下跌0.59%
每周股票复盘：威尔药业（603351）2025年境外收入占比7.80%
证券之星 · 05-17
每周股票复盘：威尔药业（603351）2025年境外收入占比7.80%
威尔药业（603351）披露2025年年度股东会会议资料，5月13日股价下跌0.68%
证券之星 · 05-13
威尔药业（603351）披露2025年年度股东会会议资料，5月13日股价下跌0.68%
每周股票复盘：威尔药业（603351）股东户数增5.16%，一季度净利升2.86%
证券之星 · 05-02
每周股票复盘：威尔药业（603351）股东户数增5.16%，一季度净利升2.86%
威尔药业（603351）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 04-29
威尔药业（603351）2026年一季报简析：营收净利润同比双双增长，盈利能力上升
图解威尔药业年报：第四季度单季净利润同比增长10.08%
证券之星 · 04-28
图解威尔药业年报：第四季度单季净利润同比增长10.08%
每周股票复盘：威尔药业（603351）股东减持44.63万股且股价涨4.27%
证券之星 · 04-19
每周股票复盘：威尔药业（603351）股东减持44.63万股且股价涨4.27%
4月13日威尔药业发布公告，股东减持44.63万股
证券之星 · 04-13
4月13日威尔药业发布公告，股东减持44.63万股
每周股票复盘：威尔药业（603351）股东吴仁荣质押857万股展期至2027年
证券之星 · 03-29
每周股票复盘：威尔药业（603351）股东吴仁荣质押857万股展期至2027年
威尔药业（603351）披露持股5%以上股东股份质押展期公告，3月25日股价下跌0.16%
证券之星 · 03-25
威尔药业（603351）披露持股5%以上股东股份质押展期公告，3月25日股价下跌0.16%
股市必读：威尔药业（603351）3月23日收盘跌5.32%，主力净流入315.51万元
证券之星 · 03-24
股市必读：威尔药业（603351）3月23日收盘跌5.32%，主力净流入315.51万元
每周股票复盘：威尔药业（603351）股东吴仁荣质押69万股股份
证券之星 · 03-22
每周股票复盘：威尔药业（603351）股东吴仁荣质押69万股股份
威尔药业（603351）披露持股5%以上股东股份质押公告，3月17日股价下跌1.11%
证券之星 · 03-17
威尔药业（603351）披露持股5%以上股东股份质押公告，3月17日股价下跌1.11%
每周股票复盘：威尔药业（603351）股东拟减持不超0.33%股份
证券之星 · 03-01
每周股票复盘：威尔药业（603351）股东拟减持不超0.33%股份
威尔药业最新公告：股东舜泰宗华拟减持不超0.33%股份
证券之星 · 02-26
威尔药业最新公告：股东舜泰宗华拟减持不超0.33%股份
威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%
证券之星 · 2025-12-04
威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%
加载更多
公司概况
公司名称：
南京威尔药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2019-01-30
主营业务：
南京威尔药业集团股份有限公司的主营业务是药用辅料及合成润滑基础油产品的研发、生产和销售。公司的主要产品是合成润滑基础油、药用辅料。公司入选南京市制造业企业百强。
发行价格：
35.50
{"stockData":{"symbol":"603351","market":"SH","secType":"STK","nameCN":"威尔药业","latestPrice":25.57,"timestamp":1780464344000,"preClose":25.68,"halted":0,"volume":384892,"delay":0,"changeRate":-0.0043,"floatShares":135000000,"shares":135000000,"eps":1.1224,"marketStatus":"交易中","change":-0.11,"latestTime":"06-03 13:25:44","open":25.41,"high":25.72,"low":25.15,"amount":9776900,"amplitude":0.0222,"askPrice":25.55,"askSize":6,"bidPrice":25.44,"bidSize":1,"shortable":0,"etf":0,"ttmEps":1.1224,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780470000000},"marketStatusCode":2,"adr":0,"adjPreClose":25.68,"symbolType":"stock","openAndCloseTimeList":[[1780450200000,1780457400000],[1780462800000,1780470000000]],"highLimit":28.25,"lowLimit":23.11,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":135439132,"isCdr":false,"pbRate":1.9,"roa":"--","peRate":22.78154,"roe":"2.07%","epsLYR":1.11,"committee":-0.632653,"marketValue":3463000000,"turnoverRate":0.0028,"status":1,"floatMarketCap":3463000000},"requestUrl":"/m/hq/s/603351","defaultTab":"news","newsList":[{"id":"2640067969","title":"股市必读：威尔药业（603351）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640067969","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640067969?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:54","pubTimestamp":1780340051,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，威尔药业报收于26.01元，上涨1.72%，换手率1.08%，成交量1.46万手，成交额3772.08万元。董秘最新回复投资者： 根据《上市公司治理准则》第七十三条，控股股东、实际控制人及其控制的其他单位不应从事与上市公司相同或相近的业务。控股股东、实际控制人应该采取有效措施避免同业竞争。且母公司其他应收款高达10.41亿元，主要为子公司往来款。投资者： 请问11月10日的股东人数多少，谢谢董秘： 尊敬的投资者，您好！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639602856","title":"每周股票复盘：威尔药业（603351）每股派现0.60元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2639602856","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639602856?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:30","pubTimestamp":1780173030,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，威尔药业报收于25.57元，较上周的26.72元下跌4.3%。本周，威尔药业5月25日盘中最高价报26.83元。威尔药业当前最新总市值34.63亿元，在化学制药板块市值排名118/150，在两市A股市值排名4184/5207。本周关注点公司公告汇总：威尔药业每股派发现金红利0.60元（含税），股权登记日为2026年6月4日。本次利润分配以公司总股本135,439,132股为基数，共计派发现金红利81,263,479.20元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638614136","title":"威尔药业（603351）披露2025年年度权益分派实施公告，5月28日股价上涨1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638614136","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638614136?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:44","pubTimestamp":1779961442,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，威尔药业报收于26.02元，较前一交易日上涨1.13%，最新总市值为35.24亿元。该股当日开盘25.9元，最高26.3元，最低25.34元，成交额达2729.71万元，换手率为0.78%。公司于近日披露《2025年年度权益分派实施公告》。公告显示，本次利润分配以公司总股本135,439,132股为基数，每股派发现金红利0.60元（含税），共计派发现金红利81,263,479.20元。个人股东持股期限不同，适用20%、10%税率或免税；QFII及沪股通股东按10%税率代扣所得税，税后每股实际派发0.54元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800032006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637761213","title":"每周股票复盘：威尔药业（603351）董事长及高管团队完成换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2637761213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637761213?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:08","pubTimestamp":1779570495,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，威尔药业报收于26.72元，较上周的27.53元下跌2.94%。本周，威尔药业5月19日盘中最高价报27.72元。公司公告汇总南京威尔药业集团股份有限公司于2026年5月19日召开第四届董事会第一次会议，选举吴仁荣为公司第四届董事会董事长。出席会议股东所持表决权占公司总股本的69.8820%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603351","BK0275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636846378","title":"威尔药业（603351）披露2025年年度股东会决议公告，5月20日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636846378","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636846378?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:33","pubTimestamp":1779273194,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，威尔药业报收于26.76元，较前一交易日下跌0.59%，最新总市值为36.24亿元。该股当日开盘26.93元，最高27.19元，最低26.36元，成交额达2121.75万元，换手率为0.59%。威尔药业于近日披露《2025年年度股东会决议公告》。所有议案均获通过，无否决议案。出席会议股东所持表决权占公司总股本的69.8820%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636627062","title":"每周股票复盘：威尔药业（603351）2025年境外收入占比7.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636627062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636627062?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:27","pubTimestamp":1778963229,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，威尔药业报收于27.53元，较上周的27.55元下跌0.07%。本周，威尔药业5月14日盘中最高价报28.9元。南京威尔药业集团股份有限公司于2026年5月13日召开2025年度暨2026年第一季度业绩说明会，通过网络互动方式就经营成果、财务指标等问题与投资者交流。会议披露2025年境外出口收入占主营业务收入7.80%，研发投入8,153.07万元，占营收6.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635735921","title":"威尔药业（603351）披露2025年年度股东会会议资料，5月13日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635735921","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635735921?lang=zh_cn&edition=full","pubTime":"2026-05-13 22:48","pubTimestamp":1778683699,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，威尔药业报收于27.76元，较前一交易日下跌0.68%，最新总市值为37.6亿元。该股当日开盘28.2元，最高28.25元，最低27.55元，成交额达2855.81万元，换手率为0.76%。近日，威尔药业发布《2025年年度股东会会议资料》。会议还听取了高级管理人员薪酬方案及独立董事述职报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300045972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632625961","title":"每周股票复盘：威尔药业（603351）股东户数增5.16%，一季度净利升2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625961","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632625961?lang=zh_cn&edition=full","pubTime":"2026-05-02 07:02","pubTimestamp":1777676539,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，威尔药业报收于27.14元，较上周的26.03元上涨4.26%。本周，威尔药业4月30日盘中最高价报27.41元。威尔药业当前最新总市值36.76亿元，在化学制药板块市值排名120/150，在两市A股市值排名4191/5200。业绩披露要点财务报告威尔药业2026年一季报显示，一季度主营收入3.56亿元，同比上升1.88%；归母净利润3763.4万元，同比上升2.86%；扣非净利润3763.05万元，同比上升3.45%；负债率29.96%，财务费用579.54万元，毛利率27.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631530720","title":"威尔药业（603351）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631530720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631530720?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:49","pubTimestamp":1777420195,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期威尔药业发布2026年一季报。截至本报告期末，公司营业总收入3.56亿元，同比上升1.88%，归母净利润3763.4万元，同比上升2.86%。本报告期威尔药业盈利能力上升，毛利率同比增幅5.53%，净利率同比增幅1.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900024041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630319381","title":"图解威尔药业年报：第四季度单季净利润同比增长10.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630319381","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630319381?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:06","pubTimestamp":1777309560,"startTime":"0","endTime":"0","summary":"证券之星消息，威尔药业2025年年报显示，当年度公司主营收入13.35亿元，同比上升2.95%；归母净利润1.51亿元，同比上升3.11%；扣非净利润1.46亿元，同比上升7.36%；其中2025年第四季度，公司单季度主营收入3.17亿元，同比上升6.88%；单季度归母净利润3690.35万元，同比上升10.08%；单季度扣非净利润3537.96万元，同比上升8.58%；负债率30.5%，投资收益2.5万元，财务费用1149.7万元，毛利率28.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628759705","title":"每周股票复盘：威尔药业（603351）股东减持44.63万股且股价涨4.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628759705","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628759705?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:15","pubTimestamp":1776539710,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，威尔药业报收于26.2元，较上周的25.88元上涨1.24%。本周，威尔药业4月16日盘中最高价报26.89元。4月14日盘中最低价报25.07元。威尔药业当前最新总市值35.49亿元，在化学制药板块市值排名123/150，在两市A股市值排名4279/5198。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627943216","title":"4月13日威尔药业发布公告，股东减持44.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627943216","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627943216?lang=zh_cn&edition=full","pubTime":"2026-04-13 19:01","pubTimestamp":1776078064,"startTime":"0","endTime":"0","summary":"证券之星消息，4月13日威尔药业发布公告《威尔药业:威尔药业关于股东集中竞价减持股份结果公告》，其股东南京舜泰宗华创业投资合伙企业(有限合伙)于2026年3月23日至2026年4月10日间合计减持44.63万股，占公司目前总股本的0.3295%，变动期间该股股价上涨4.27%，截止4月10日收盘报25.88元。股东增减持详情见下表：根据威尔药业2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300026658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623498333","title":"每周股票复盘：威尔药业（603351）股东吴仁荣质押857万股展期至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=2623498333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623498333?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:42","pubTimestamp":1774730530,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，威尔药业报收于24.78元，较上周的24.82元下跌0.16%。截至公告日，吴仁荣累计质押股份926万股，占其持股总数的49.99%。公司控股股东及其一致行动人合计累计质押股份2381万股，占其所持股份比例的42.87%，占公司总股本的17.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603351","BK0275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622772029","title":"威尔药业（603351）披露持股5%以上股东股份质押展期公告，3月25日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622772029","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622772029?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:21","pubTimestamp":1774430463,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘，威尔药业报收于24.71元，较前一交易日下跌0.16%，最新总市值为33.47亿元。近日，威尔药业发布《关于持股5%以上股东股份质押展期的公告》。公告显示，公司持股5%以上股东吴仁荣将其持有的857万股公司股份质押展期，展期后到期日为2027年3月24日，质权人为南京证券股份有限公司，质押融资用途为自身资金需求。截至公告日，吴仁荣累计质押股份926万股，占其持股总数的49.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500032668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621819930","title":"股市必读：威尔药业（603351）3月23日收盘跌5.32%，主力净流入315.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621819930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621819930?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:57","pubTimestamp":1774295828,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，威尔药业报收于23.5元，下跌5.32%，换手率0.82%，成交量1.11万手，成交额2636.56万元。当日关注点来自交易信息汇总：威尔药业股价连续3日下跌，累计跌幅达9.74%，但主力资金在前10个交易日内呈净流入态势。来自交易信息汇总：3月23日主力资金净流入315.51万元，占总成交额11.97%，与散户资金净流出形成明显对比。交易信息汇总股价提醒3月23日威尔药业收盘报23.5元，跌5.32%，当日成交111.01万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621548791","title":"每周股票复盘：威尔药业（603351）股东吴仁荣质押69万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2621548791","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621548791?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:38","pubTimestamp":1774121892,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，威尔药业报收于24.82元，较上周的26.24元下跌5.41%。本周，威尔药业3月16日盘中最高价报26.34元。3月20日盘中最低价报24.81元。威尔药业当前最新总市值33.62亿元，在化学制药板块市值排名127/150，在两市A股市值排名4316/5190。本周关注点公司公告汇总：持股5%以上股东吴仁荣质押69万股公司股份，占其所持股份比例3.73%。本次质押后，吴仁荣累计质押股份926万股，占其所持股份比例49.99%。已质押股份和未质押股份中均无限售股或冻结股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0275","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620751475","title":"威尔药业（603351）披露持股5%以上股东股份质押公告，3月17日股价下跌1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620751475","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620751475?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:57","pubTimestamp":1773759430,"startTime":"0","endTime":"0","summary":"近日，威尔药业发布《关于持股5%以上股东股份质押的公告》。公告显示，公司持股5%以上股东吴仁荣将其持有的69万股公司股份进行质押，质押起始日为2026年3月16日，到期日为2027年3月16日，质权人为南京证券股份有限公司，占其所持股份比例3.73%，占公司总股本比例0.51%，质押融资用途为自身资金需求。公司控股股东及其一致行动人合计累计质押股份2381万股，占其所持股份比例42.87%，占公司总股本比例17.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","BK0239","603351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616845411","title":"每周股票复盘：威尔药业（603351）股东拟减持不超0.33%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845411","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845411?lang=zh_cn&edition=full","pubTime":"2026-03-01 03:00","pubTimestamp":1772305238,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，威尔药业报收于27.29元，较上周的27.08元上涨0.78%。本周，威尔药业2月25日盘中最高价报28.0元。威尔药业当前最新总市值36.96亿元，在化学制药板块市值排名126/150，在两市A股市值排名4330/5189。该股东拟于2026年3月23日至4月10日通过集中竞价交易方式减持不超过446,340股，即不超过公司总股本的0.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603351","BK0239","BK0275"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614011868","title":"威尔药业最新公告：股东舜泰宗华拟减持不超0.33%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2614011868","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614011868?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:41","pubTimestamp":1772098860,"startTime":"0","endTime":"0","summary":"威尔药业(603351.SH)公告称，股东南京舜泰宗华创业投资合伙企业（有限合伙）拟自2026年3月23日至4月10日期间，通过集中竞价交易方式减持公司股份不超过446,340股，即不超过公司总股本的0.33%；减持原因为股东资金需求；股份来源为首次公开发行前持有及上市后资本公积转增股本取得。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600028095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0275","603351","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588884838","title":"威尔药业（603351）披露关于完成工商备案登记的公告，12月4日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884838?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:30","pubTimestamp":1764858645,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，威尔药业报收于26.84元，较前一交易日下跌1.54%，最新总市值为36.35亿元。该股当日开盘27.11元，最高27.2元，最低26.4元，成交额达3017.34万元，换手率为0.83%。近日，威尔药业发布关于完成工商备案登记的公告。公告显示，南京威尔药业集团股份有限公司于2025年10月29日召开第三届董事会第十三次会议，并于2025年11月14日召开2025年第一次临时股东大会，审议通过取消监事会并修订《公司章程》的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603351","BK0275"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780464358269,"stockEarnings":[{"period":"1week","weight":-0.0202},{"period":"1month","weight":-0.0538},{"period":"3month","weight":-0.0035},{"period":"6month","weight":-0.0432},{"period":"1year","weight":-0.0648},{"period":"ytd","weight":-0.0131}],"compareEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.009},{"period":"3month","weight":-0.0018},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2174},{"period":"ytd","weight":0.0268}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京威尔药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6687人(较上一季度增加5.16%)","perCapita":"20254股","listingDate":"2019-01-30","address":"江苏省南京市六合区南京化学工业园区长丰河西路99号","registeredCapital":"13543万元","survey":" 南京威尔药业集团股份有限公司的主营业务是药用辅料及合成润滑基础油产品的研发、生产和销售。公司的主要产品是合成润滑基础油、药用辅料。公司入选南京市制造业企业百强。","listedPrice":35.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威尔药业(603351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威尔药业,603351,威尔药业股票,威尔药业股票老虎,威尔药业股票老虎国际,威尔药业行情,威尔药业股票行情,威尔药业股价,威尔药业股市,威尔药业股票价格,威尔药业股票交易,威尔药业股票购买,威尔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威尔药业(603351)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威尔药业(603351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}